GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman LlcAquestive Therapeutics Faces Securities Fraud Suit Over FDA Approval Claims
Class action lawsuit filed against $AQST alleging misleading statements about FDA approval timeline for Anaphylm and concealed human factors risks.
AQSTsecurities fraudclass action lawsuit